SCN9A and epilepsy: However, the publications identifying an association between SCN9A and epilepsy have led to its widespread incorporation into monogenic inherited seizure disorder diagnostic testing panels [33], including Athena Diagnostics (MA, USA) [34], Blueprint Genetics (Finland) [35], Centogene (Germany) [36], Dynacare (Canada) [37], EGL Genetics (GA, USA) [38], Invitae (CA, USA) [39], Mayo Clinic Labs (MN & FL USA) [40].